OIM
IRWD icon

Oracle Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Oracle Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,935,361
Closed -$24.8M – 30
2014
Q2 		$24.8M Sell
1,935,361
-268,769
-12% -$2.92M 3.02% 12
2014
Q1 		$22.7M Buy
2,204,130
+913,410
+71% +$10.3M 2.6% 12
2013
Q4 		$12.6M Sell
1,290,720
-29,850
-2% -$268K 1.73% 17
2013
Q3 		$13.1M Sell
1,320,570
-1,286
-0.1% -$12.6K 1.87% 15
2013
Q2 		$11M Buy
+1,321,856
New +$16M 1.9% 16

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Oracle Investment Management's IRWD Position: Q3 2014 in Review

Oracle Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2014, closing a stake of 1,935,361 shares — an estimated $24.8M sold.

Oracle Investment Management first reported a position in IRWD in Q2 2013 and held it in 5 quarters. The position peaked at $24.8M in Q2 2014. 140 funds tracked by Wall St. Rank hold IRWD as of Q3 2014.

  • Oracle Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Oracle Investment Management sold 1,935,361 Ironwood Pharmaceuticals shares in Q3 2014, an estimated $24.8M.
  • Oracle Investment Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Oracle Investment Management's Ironwood Pharmaceuticals position peaked at $24.8M in Q2 2014.
  • 140 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2014.

Based on Oracle Investment Management's 13F filing for Q3 2014, filed 14 Nov 2014.